Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26610878.
- Also identified by DOI 10.1016/j.jacc.2015.09.075.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transthyretin amyloidosis is a fatal disorder that is characterized primarily by progressive neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant inheritance) and a wild-type form (with predominant cardiac involvement). This article guides clinicians as to when the disease should be suspected, describes the appropriate diagnostic evaluation for those with known or suspected amyloidosis, and reviews the interventions currently available for affected patients.
Medical subject headings
- Amyloid Neuropathies, Familial